It's an upgrade worth making, but it comes down to your privacy concerns.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

On Wednesday, OpenAI took its biggest step yet towards full technological independence with the unveiling of a new AI chip, ...

OpenAI unveiled its first custom AI chip with Broadcom, while Qualcomm agreed to buy Modular to strengthen its AI software ...

Most coverage treats “the Palantir Mafia” as a cute analogy — a nod to the PayPal Mafia that gave us Tesla, LinkedIn, YouTube and Yelp. That framing undersells it. The Palantir Mafia is not analogous ...